share_log

3M | 10-Q: Q2 2024 Earnings Report

3M | 10-Q: Q2 2024 Earnings Report

3M | 10-Q:2024財年二季報
美股SEC公告 ·  2024/07/26 23:13

Moomoo AI 已提取核心訊息

3M reported second quarter 2024 results with net income of $1.2 billion, or $2.17 per share, compared to a loss of $7.2 billion in Q2 2023. Sales decreased 0.5% year-over-year to $6.3 billion, while operating income margin improved to 20.3%. The company successfully completed the separation of its healthcare business Solventum on April 1, 2024.Operating performance showed strength across segments, with Safety & Industrial operating margins increasing to 22.2% and Transportation & Electronics margins rising to 20.0%. The company benefited from productivity initiatives, lower raw material costs, and reduced restructuring charges. However, Consumer segment sales declined 2.4% due to softer discretionary demand.The company made significant progress on strategic initiatives, including the Combat Arms Earplugs settlement with over 99% claimant participation and continued execution of its PFAS manufacturing exit plan. 3M maintained strong liquidity with $10.4 billion in cash and marketable securities as of June 30, 2024. The quarterly dividend was reset to $0.70 per share following the Solventum spin-off.
3M reported second quarter 2024 results with net income of $1.2 billion, or $2.17 per share, compared to a loss of $7.2 billion in Q2 2023. Sales decreased 0.5% year-over-year to $6.3 billion, while operating income margin improved to 20.3%. The company successfully completed the separation of its healthcare business Solventum on April 1, 2024.Operating performance showed strength across segments, with Safety & Industrial operating margins increasing to 22.2% and Transportation & Electronics margins rising to 20.0%. The company benefited from productivity initiatives, lower raw material costs, and reduced restructuring charges. However, Consumer segment sales declined 2.4% due to softer discretionary demand.The company made significant progress on strategic initiatives, including the Combat Arms Earplugs settlement with over 99% claimant participation and continued execution of its PFAS manufacturing exit plan. 3M maintained strong liquidity with $10.4 billion in cash and marketable securities as of June 30, 2024. The quarterly dividend was reset to $0.70 per share following the Solventum spin-off.
3M公佈了2024年第二季度的業績,凈利潤爲12億元,或每股2.17美元,相較於2023年第二季度的72億元虧損。銷售額同比下降0.5%,爲63億元,而營業利潤率改善至20.3%。該公司於2024年4月1日成功完成了與醫療保健業務Solventum的分離。各個業務板塊的運營表現強勁,安全與工業的營業利潤率提高到22.2%,交通與電子的利潤率上升至20.0%。公司受益於生產率提升、原材料成本降低和重組費用減少。然而,由於可選擇性消費需求疲軟,消費板塊的銷售額下降了2.4%。公司在戰略倡議上取得了重大進展,包括與超過99%索賠人蔘與的戰鬥耳塞和解,以及持續執行其PFAS製造退出計劃。到2024年6月30日,3M保持強勁的流動性,現金及可交易證券總額爲104億元。由於Solventum的分拆,季度股息調整爲每股0.70美元。
3M公佈了2024年第二季度的業績,凈利潤爲12億元,或每股2.17美元,相較於2023年第二季度的72億元虧損。銷售額同比下降0.5%,爲63億元,而營業利潤率改善至20.3%。該公司於2024年4月1日成功完成了與醫療保健業務Solventum的分離。各個業務板塊的運營表現強勁,安全與工業的營業利潤率提高到22.2%,交通與電子的利潤率上升至20.0%。公司受益於生產率提升、原材料成本降低和重組費用減少。然而,由於可選擇性消費需求疲軟,消費板塊的銷售額下降了2.4%。公司在戰略倡議上取得了重大進展,包括與超過99%索賠人蔘與的戰鬥耳塞和解,以及持續執行其PFAS製造退出計劃。到2024年6月30日,3M保持強勁的流動性,現金及可交易證券總額爲104億元。由於Solventum的分拆,季度股息調整爲每股0.70美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息